ROR1 and cancer: This review has discussed how ROR1 is upregulated in CSC tumor populations across numerous cancers and is responsible for maintaining stemness, driving aggressive disease progression and metastasis and serving not only as a marker of poor prognosis but also as a functional driver of adverse patient outcomes.